Condition

Cancer, Advanced Solid Tumors (2)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (2)

Sponsor

ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.) (1)

Sumitomo Pharma Oncology, Inc. (1)

Collaborator

Intervention

arq 197 (1)

bbi503 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

cancer, advanced solid tumors

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Cancer, Advanced Solid Tumors Trial in Canada, United States (BBI503)

Completed

Cancer, Advanced Solid Tumors

BBI503

Scottsdale, Arizona
+18 more

Apr 4, 2022

Cancer, Advanced Solid Tumors Trial in Sutton (ARQ 197)

Completed

Cancer, Advanced Solid Tumors

ARQ 197

Sutton, Surrey, United Kingdom

The Royal Marsden Hospital

Jul 20, 2012